Isadora Lenoel

Isadora Lenoel

Auto-generated profile, based on publicly available information

Isadora Lenoel

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié-Salpêtrière, Paris, France

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ILIsadora Lenoel
Isadora Lenoel
MRMatthieu Ribon
Matthieu Ribon
FLFélicie Lorenc
Félicie Lorenc
ADAurélien Diebold
Aurélien Diebold
CPClementine E. Philibert
Clementine E. Philibert
CLChristian S. Lobsiger
Christian S. Lobsiger
TANK-Binding Kinase 1 (TBK1) is involved in autophagy and immune signaling. Dominant loss-of-function mutations in TBK1 have been linked to Amyotrophic Lateral Sclerosis (ALS), Fronto-temporal dementia (FTD), and ALS/FTD. However, pathogenic mechanisms remain unclear, particularly the cell-type specific disease contributions of TBK1 mutations. Here, we show that deleting Tbk1 from mouse motor neurons does not induce transcriptional stress, despite lifelong signs of autophagy deregulations. Conversely, Tbk1 deletion in microglia alters their homeostasis and reactive responses. In both spinal cord and brain, Tbk1 deletion leads to a pro-inflammatory, primed microglial signature with features of ageing and neurodegeneration. While it does not induce or modify ALS-like motor neuron damage, microglial Tbk1 deletion is sufficient to cause early FTD-like social recognition deficits. This phenotype is linked to focal microglial activation and T cell infiltration in the substantia nigra pars reticulata and pallidum. Our results reveal that part of TBK1-linked FTD disease originates from microglial dysfunction.

17 July 2025 in Genome Research
Verified
Journal Article
Open access
IMIrene Mei
Irene Mei
SNSusanne Nichterwitz
Susanne Nichterwitz
MLMelanie Leboeuf
Melanie Leboeuf
JNJik Nijssen
Jik Nijssen
ILIsadora Lenoel
Isadora Lenoel
EHEva Hedlund
Eva Hedlund
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of motor neurons (MNs) that innervate skeletal muscles. However, certain MN groups including ocular MNs, are relatively resilient. To reveal key drivers of resilience versus vulnerability in ALS, we investigate the transcriptional dynamics of four distinct MN populations in SOD1G93A ALS mice using LCM-seq and single-molecule fluorescent in situ hybridization. We find that resilient ocular MNs regulate few genes in response to disease. Instead, they exhibit high baseline gene expression of neuroprotective factors, including En1, Pvalb, Cd63, and Gal, some of which vulnerable MNs upregulate during disease. Vulnerable MN groups upregulate both detrimental and regenerative responses to ALS and share pathway activation, indicating that breakdown occurs through similar mechanisms across vulnerable neurons, albeit with distinct timing. Meta-analysis across four rodent mutant Sod1 MN transcriptome data sets identify a shared vulnerability code of 39 genes, including Atf4, Nupr1, Ddit3, and Penk, involved in apoptosis, as well as a proregenerative and antiapoptotic signature consisting of Atf3, Vgf, Ina, Sprr1a, Fgf21, Gap43, Adcyap1, and Mt1. Machine learning using genes upregulated in SOD1G93A spinal MN predicts disease in human stem cell–derived SOD1E100G MNs and shows that dysregulation of VGF, INA, and PENK is a strong disease predictor across species and SOD1 mutations. Our study reveals MN population-specific gene expression and temporal disease-induced regulation that together provide a basis to explain ALS selective vulnerability and resilience and that can be used to predict disease.

17 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
IMIrene Mei
Irene Mei
SNSusanne Nichterwitz
Susanne Nichterwitz
MLMelanie Leboeuf
Melanie Leboeuf
JNJik Nijssen
Jik Nijssen
ILIsadora Lenoel
Isadora Lenoel
EHEva Hedlund
Eva Hedlund
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of motor neurons that innervate skeletal muscles. However, certain motor neuron groups including ocular motor neurons, are relatively resilient. To reveal key drivers of resilience versus vulnerability in ALS, we investigate the transcriptional dynamics of four distinct motor neuron populations in SOD1G93A ALS mice using LCM-seq and single molecule fluorescent in situ hybridization. We find that resilient ocular motor neurons regulate few genes in response to disease. Instead, they exhibit high baseline gene expression of neuroprotective factors including En1 , Pvalb, Cd63 and Gal, some of which vulnerable motor neurons upregulate during disease. Vulnerable motor neuron groups upregulate both detrimental and regenerative responses to ALS and share pathway activation, indicating that breakdown occurs through similar mechanisms across vulnerable neurons, albeit with distinct timing. Meta-analysis across four rodent mutant SOD1 motor neuron transcriptome datasets identify a shared vulnerability code of 39 genes including e.g Atf4 , Nupr1 , Ddit3 and Penk, involved in apoptosis, as well as a proregenerative and anti-apoptotic signature consisting of Atf3 , Vgf , Ina , Sprr1a, Fgf21, Gap43, Adcyap1, and Mt1 . Machine learning using genes upregulated in SOD1G93A spinal motor neuron predicts disease in human stem cell-derived SOD1E100G motor neurons, and shows that dysregulation of VGF , INA, PENK and NTS are strong disease-predictors across species and SOD1 mutations. Our study reveals motor neuron population-specific gene expression and temporal disease-induced regulation that together provide a basis to explain ALS selective vulnerability and resilience and that can be used to predict disease.

8 April 2026
Verified
Thesis
Closed access
ILIsadora Lenoël
Isadora Lenoël
Étude des rôles de TBK1 dans les motoneurones et les cellules microgliales, et leur implication dans la pathogenèse de la SLA et de la DFT: La TANK-Binding Kinase 1 (TBK1) est une kinase ubiquitaire notamment impliquée dans l'autophagie et l'immunité innée. Des mutations perte-de-fonctions ont été identifiées chez des patients atteints de la Sclérose latérale amyotrophique (SLA) et de démence fronto-temporale (DFT), et de SLA/DFT. Cependant, les mécanismes pathogènes sont encore méconnus, particulièrement la contribution des mutations de TBK1 dans les différents types cellulaires. En se concentrant sur les motoneurones et les cellules microgliales, nous avons montré que la délétion de Tbk1 spécifiquement dans les cellules microgliales est suffisante pour induire des troubles de la mémoire sociale, et une signature de microglie pré-activée, chez la souris. Nous avons montré que la délétion de Tbk1 dans les motoneurones n'induit pas de signature transcriptionnelle de stress, malgré la présence d'inclusions intra-cellulaires de p62 dans les motoneurones. En revanche, la délétion de Tbk1 dans la microglie modifie fortement leur réponse immunitaire. Dans la moelle épinière, la délétion de Tbk1 dans la microglie induit une augmentation de la densité microgliale, sans causer de dommages aux motoneurones. Enfin, dans le cerveau, la délétion de Tbk1 dans la microglie induit une signature similaire à celle d'une microglie âgée et pro-inflammatoire, et est suffisante pour induire des troubles de la mémoire sociale, en corrélation avec les symptômes de perte de mémoire des patients SLA/DFT mutés dans TBK1. Ces résultats suggèrent que l'altération microgliale peut être à l'origine d'une partie de la pathologie de la SLA/DFT liée à TBK1.